ACTC Financials 07/15/2014 22:03:40
Advanced Cell Technology, Inc.
Period Ending Dec 31, 2013 Dec 31, 2012 Dec 31, 2011 Dec 31, 2010
Total Revenue 225 466 506 725
Cost of Revenue 82 117 344 217
Gross Profit 143 349 162 508
Operating Expenses
Research and Development 11,565 14,159 9,754 7,461
Sales, General and Admin. 12,057 11,433 7,436 14,243
Non-Recurring Items 6,229 - - -
Other - - - -
Operating Income (29,708) (25,243) (17,321) (32,329)
Income From Continuing Operations
Add'l Income/Expense Items 123 (8,237) (36,655) (21,451)
Earnings Before Interest and Tax (29,585) (33,480) (53,682) (42,647)
Interest Expense 1,438 1,105 1,511 11,726
Earnings Before Tax (31,022) (34,584) (55,193) (54,373)
Income Tax - - - -
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (30,584) (34,584) (55,193) (54,176)
Non Recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (31,022) (34,584) (55,193) (54,373)
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders (31,022) (34,584) (55,193) (54,373)